{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:59:31Z","timestamp":1786118371002,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":160,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Notes"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.biotno.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:17:08Z","timestamp":1786025828000},"page":"156-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Mala M.","family":"Parab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4582-2054","authenticated-orcid":false,"given":"Pramodkumar P.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh S.","family":"Chhajed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetanjali","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshitij","family":"Bapat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debjani","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerona","family":"Boruah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biotno.2026.06.002_bib1","article-title":"Breast cancer: global patterns of incidence, mortality, and trends","volume":"41:10528","author":"Sedeta","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.biotno.2026.06.002_bib2","author":"Patel","year":"2026","journal-title":"Tamoxifen. Treasure Island: StatPearls"},{"key":"10.1016\/j.biotno.2026.06.002_bib3","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2020.1092","article-title":"Excellent response to erlotinib in breast carcinoma with rare EGFR mutation\u2014a case report","volume":"14","author":"Kumar Singh","year":"2020","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.biotno.2026.06.002_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188789","article-title":"Can EGFR be a therapeutic target in breast cancer?","volume":"1877","author":"Li","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.biotno.2026.06.002_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-018-0804-2","article-title":"Kinase-targeted cancer therapies: progress, challenges and future directions","volume":"17","author":"Bhullar","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1016\/j.biotno.2026.06.002_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13045-022-01311-6","article-title":"Emerging strategies to overcome resistance to third-generation EGFR inhibitors","volume":"15","author":"Shi","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.biotno.2026.06.002_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109157","article-title":"Design, synthesis, and antitumor evaluation of new pyridazinone scaffolds as dual EGFR\/VEGFR-2 kinase inhibitors and apoptotic cells inducers","volume":"166","author":"Ewieda","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.biotno.2026.06.002_bib8","article-title":"New pyrazolyl-thiazolidinone\/thiazole derivatives as celecoxib\/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory\/anti-proliferative activities, apoptosis, molecular modelling and ADME studies","volume":"38","author":"Fadaly","year":"2023","journal-title":"J Enzym Inhib Med Chem"},{"key":"10.1016\/j.biotno.2026.06.002_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.biotno.2026.06.002_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/molecules27030819","article-title":"Structural insight and development of EGFR tyrosine kinase inhibitors","volume":"27","author":"Amelia","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biotno.2026.06.002_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/LCTT.S117944","article-title":"Egfr T790M: revealing the secrets of a gatekeeper","volume":"8","author":"Ko","year":"2017","journal-title":"Lung Cancer Targets Ther"},{"key":"10.1016\/j.biotno.2026.06.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107403","article-title":"Discovery of novel pyrazole based urea\/thiourea derivatives as multiple targeting VEGFR-2, EGFRWT, EGFRT790M tyrosine kinases and COX-2 inhibitors, with anti-cancer and anti-inflammatory activities","volume":"147","author":"Fadaly","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.biotno.2026.06.002_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108728","article-title":"Novel 3,4-diaminothieno[2,3-b]thiophene-2,5-dicarbohydrazide-based scaffolds as EGFRWT, EGFRT790M, and tubulin polymerization inhibitors with anti-proliferative activity","volume":"163","author":"Aboelez","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.biotno.2026.06.002_bib15","series-title":"In: Proceedings of the ACS Meeting; Philadelphia, PA","article-title":"Molecular docking using ArgusLab, an efficient shape-based search algorithm and AScore scoring function","author":"Thompson","year":"2004"},{"key":"10.1016\/j.biotno.2026.06.002_bib16","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1021\/ja00051a040","article-title":"UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations","volume":"114","author":"Rappe","year":"1992","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.biotno.2026.06.002_bib17","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.biotno.2026.06.002_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biotno.2026.06.002_bib19","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biotno.2026.06.002_bib20","series-title":"Discovery Studio","year":"2020"},{"key":"10.1016\/j.biotno.2026.06.002_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.biotno.2026.06.002_bib22","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/jp003919d","article-title":"Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate Quantum chemical calculations on peptides","volume":"105","author":"Kaminski","year":"2001","journal-title":"J Phys Chem B"},{"issue":"33\u20138","key":"10.1016\/j.biotno.2026.06.002_bib23","first-page":"27","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph"},{"key":"10.1016\/j.biotno.2026.06.002_bib25","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biotno.2026.06.002_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/prot.340120407","article-title":"Stereochemical quality of protein structure coordinates","volume":"12","author":"Morris","year":"1992","journal-title":"Proteins Struct Funct Bioinf"},{"key":"10.1016\/j.biotno.2026.06.002_bib27","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci"},{"key":"10.1016\/j.biotno.2026.06.002_bib28","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gky473","article-title":"CASTp 3.0: computed atlas of surface topography of proteins","volume":"46","author":"Tian","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.biotno.2026.06.002_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.biotno.2026.06.002_bib30","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera?a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.biotno.2026.06.002_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.biotno.2026.06.002_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2016.02.001","article-title":"Design, synthesis and molecular modeling studies of few chalcone analogues of benzimidazole for epidermal growth factor receptor inhibitor in search of useful anticancer agent","volume":"61","author":"Chhajed","year":"2016","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.biotno.2026.06.002_bib33","series-title":"Vogel\u2019s Textbook of Practical Organic Chemistry","author":"Furniss","year":"2011"},{"key":"10.1016\/j.biotno.2026.06.002_bib34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.biotno.2026.06.002_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107881","article-title":"Novel benzenesulfonamide derivatives as potential selective carbonic anhydrase IX, XII inhibitors with anti-proliferative activity: design, synthesis and in silico studies","volume":"153","author":"Fadaly","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.biotno.2026.06.002_bib36","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/OP.23.00794","article-title":"Breast cancer brain metastasis: a comprehensive review","volume":"20","author":"Raghavendra","year":"2024","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.biotno.2026.06.002_bib37","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/neuonc\/noaa285","article-title":"The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis","volume":"23","author":"Kuksis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.biotno.2026.06.002_bib38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(18)30256-0","article-title":"Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study","volume":"19","author":"Murthy","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.biotno.2026.06.002_bib39","doi-asserted-by":"crossref","DOI":"10.1007\/s11224-020-01500-4","article-title":"De-novo design and synthesis of conformationally restricted thiazolidine-2,4-dione analogues: highly selective PPAR-\u03b3 agonist in search of anti-diabetic agent","author":"Chhajed","year":"2020","journal-title":"Struct Chem"},{"key":"10.1016\/j.biotno.2026.06.002_bib40","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00018-008-7440-8","article-title":"The epidermal growth factor receptor family: biology driving targeted therapeutics","volume":"65","author":"Wieduwilt","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.biotno.2026.06.002_bib41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejmech.2019.04.012","article-title":"Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors","volume":"173","author":"Celik","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.biotno.2026.06.002_bib42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jmgm.2009.08.012","article-title":"Induced-fit docking studies of the active and inactive states of protein tyrosine kinases","volume":"28","author":"Zhong","year":"2009","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.biotno.2026.06.002_bib43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.fitote.2008.06.007","article-title":"Cytotoxic activity screening of some indigenous Thai plants","volume":"79","author":"Prayong","year":"2008","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biotno.2026.06.002_bib44","first-page":"2993","article-title":"Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells","volume":"29","author":"Badisa","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.biotno.2026.06.002_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22171","article-title":"Sodium acetate, sodium acid pyrophosphate, and citric acid impacts on isolated peripheral lymphocyte viability, proliferation, and DNA damage","volume":"32","author":"Abd\u2010Elhakim","year":"2018","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.biotno.2026.06.002_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13104-015-1000-8","article-title":"Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays","volume":"8","author":"van Tonder","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.biotno.2026.06.002_bib47","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1158\/1078-0432.CCR-13-1610","article-title":"Molecular pathways: resistance to kinase inhibitors and implications for therapeutic strategies","volume":"20","author":"Lovly","year":"2014","journal-title":"Clin Cancer Res"}],"container-title":["Biotechnology Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665906926000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665906926000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:42:27Z","timestamp":1786030947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2665906926000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":45,"alternative-id":["S2665906926000103"],"URL":"https:\/\/doi.org\/10.1016\/j.biotno.2026.06.002","relation":{},"ISSN":["2665-9069"],"issn-type":[{"value":"2665-9069","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Notes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotno.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}